Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib ...Middle East

Marketing authorisation in the European Economic Area anticipated in H1 2023 LEIDEN, Netherlands, Oct. 28, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) announces today that its Marketing Authorisation Application (MAA)...

Hence then, the article about pharming announces european medicines agency ema validates its marketing authorisation application under accelerated assessment for leniolisib was published today ( Friday 28/10/2022 - 08:17 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib )

Also on site :

• ‘Cherry Pie’ Legend Makes Heartbreaking Health Admission Nearly 40 Years Later: ‘I’m Crumbling Inside’
• Kaigene Enters into Exclusive Licensing Agreement with Taisho Pharmaceutical for Next-Generation Autoimmune Asset KG006 in Japan
• Celebrities Love Jenny Bird's 'Stunning' Dainty Gold Jewelry, and You Can Snag Petite Hoop Earrings for 35% Off